Companion Animal Vaccines Market Size, Share, Trends, & Industry Analysis Report By Route of Administration (Subcutaneous, Intramuscular, and Intranasal), By Product, By Animal Type, By Distribution Channel, By Region

Description

List of Tables

The companion animal vaccines market size is expected to reach USD 8,506.56 million by 2034, according to a new study by Polaris Market Research. The report "Companion Animal Vaccines Market Size, Share, Trends, & Industry Analysis Report: By Route of Administration (Subcutaneous, Intramuscular, and Intranasal), By Product, By Animal Type, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The companion animal vaccines market comprises biologic products developed to protect domestic pets such as dogs, cats, and other non-livestock animals from various infectious diseases. This market continues to evolve as pet humanization intensifies and pet owners increasingly prioritize preventative healthcare. Advancements in veterinary immunology, coupled with rising awareness of zoonotic disease risks, are driving robust demand for both core and non-core vaccines. The industry is witnessing increased adoption of combination vaccines and novel delivery platforms, such as needle-free injectors and oral formulations, enhancing compliance and safety. Rising incidences of viral and bacterial infections in household animals have also catalyzed innovation in vaccine development, particularly in recombinant and DNA-based technologies.

The market growth is accelerated by the expansion of pet insurance coverage and greater veterinary healthcare expenditure, which collectively support higher vaccine uptake. Market players are investing in R&D to develop long-acting, cross-protective, and strain-specific vaccines, responding to evolving pathogen profiles and antigenic variability. Stringent regulatory oversight ensures product efficacy and safety, prompting manufacturers to integrate advanced quality assurance practices. Opportunities lie in personalized veterinary medicine and the application of artificial intelligence (AI) in vaccine development pipelines, which shorten time-to-market and improve targeting accuracy. The increasing role of veterinary clinics and digital health platforms in raising vaccine awareness, coupled with growing collaboration between pharmaceutical firms and veterinary institutions, signals a favorable outlook for market expansion.

Companion Animal Vaccines Market Report Highlights

By product, in 2024, the attenuated live vaccines segment held the largest share due to their robust immunogenicity and rapid onset of protection.

Based on animal type, the feline segment is expected to witness the highest CAGR during the forecast period due to increasing awareness around feline-specific pathogens such as feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV).

In 2024, the North America companion animal vaccines market held the largest share due to the region's stringent pet vaccination laws, high veterinary service utilization, and strong pharmaceutical R&D presence.

The Asia Pacific companion animal vaccines market is projected to register the highest CAGR during the forecast period, driven by a rapidly growing pet population, particularly in emerging economies such as China, India, and Southeast Asia.

A few global key market players include Zoetis; Merck & Co., Inc.; Boehringer Ingelheim Animal Health; Elanco; Virbac; Phibro Animal Health Corporation; Calier; Ceva; Bimeda Biologicals; and Neogen Corporation.

Polaris Market Research has segmented the market report on the basis of product, route of administration, animal type, distribution channel, and region:

By Product Outlook (Revenue, USD Million, 2020-2034)

Attenuated Live Vaccines

Inactivated Vaccines

Subunit Vaccines

DNA Vaccines

Recombinant Vaccines

By Route of Administration Outlook (Revenue, USD Million, 2020-2034)

Subcutaneous

Intramuscular

Intranasal

By Animal Type Outlook (Revenue, USD Million, 2020-2034)

Canine

Feline

Others

By Distribution Channel Outlook (Revenue, USD Million, 2020-2034)

Retail

E-Commerce

Hospital/Clinic Pharmacy

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Product Code: PM5752

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Companion Animal Vaccines Market Insights

4.1. Companion Animal Vaccines Market - Market Snapshot
4.2. Companion Animal Vaccines Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Pet Ownership and Humanization of Pets
  - 4.2.1.2. Growing Awareness About Zoonotic Diseases
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Companion Animal Vaccines Market Power Rating Trends
4.6. Value Chain Analysis

5. Companion Animal Vaccines Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Companion Animal Vaccines Market, by Product, 2020-2034 (USD Million)
5.3. Attenuated Live Vaccines
- 5.3.1. Companion Animal Vaccines Market, by Attenuated Live Vaccines, by Region, 2020-2034 (USD Million)
5.4. Inactivated Vaccines
- 5.4.1. Companion Animal Vaccines Market, by Inactivated Vaccines, by Region, 2020-2034 (USD Million)
5.5. Subunit Vaccines
- 5.5.1. Companion Animal Vaccines Market, by Subunit Vaccines, by Region, 2020-2034 (USD Million)
5.6. DNA Vaccines
- 5.6.1. Companion Animal Vaccines Market, by DNA Vaccines, by Region, 2020-2034 (USD Million)
5.7. Recombinant Vaccines
- 5.7.1. Companion Animal Vaccines Market, by Recombinant Vaccines, by Region, 2020-2034 (USD Million)

6. Companion Animal Vaccines Market, by Route of Administration

6.1. Key Findings
6.2. Introduction
- 6.2.1. Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
6.3. Subcutaneous
- 6.3.1. Companion Animal Vaccines Market, by Subcutaneous, by Region, 2020-2034 (USD Million)
6.4. Intramuscular
- 6.4.1. Companion Animal Vaccines Market, by Intramuscular, by Region, 2020-2034 (USD Million)
6.5. Intranasal
- 6.5.1. Companion Animal Vaccines Market, by Intranasal, by Region, 2020-2034 (USD Million)

7. Companion Animal Vaccines Market, by Animal Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
7.3. Canine
- 7.3.1. Companion Animal Vaccines Market, by Canine, by Region, 2020-2034 (USD Million)
7.4. Feline
- 7.4.1. Companion Animal Vaccines Market, by Feline, by Region, 2020-2034 (USD Million)
7.5. Other
- 7.5.1. Companion Animal Vaccines Market, by Other, by Region, 2020-2034 (USD Million)

8. Companion Animal Vaccines Market, by Distribution Channel

8.1. Key Findings
8.2. Introduction
- 8.2.1. Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
8.3. Retail
- 8.3.1. Companion Animal Vaccines Market, by Retail, by Region, 2020-2034 (USD Million)
8.4. E-Commerce
- 8.4.1. Companion Animal Vaccines Market, by E-Commerce, by Region, 2020-2034 (USD Million)
8.5. Hospital/ Clinic Pharmacy
- 8.5.1. Companion Animal Vaccines Market, by Hospital/ Clinic Pharmacy, by Region, 2020-2034 (USD Million)

9. Companion Animal Vaccines Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Companion Animal Vaccines Market Assessment, By Geography, 2020-2034 (USD Million)
9.3. Companion Animal Vaccines Market - North America
- 9.3.1. North America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.3.2. North America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.3.3. North America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.3.4. North America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.3.5. Companion Animal Vaccines Market - US
  - 9.3.5.1. US: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.3.5.2. US: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.3.5.3. US: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.3.5.4. US: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.3.6. Companion Animal Vaccines Market - Canada
  - 9.3.6.1. Canada: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.3.6.2. Canada: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.3.6.3. Canada: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.3.6.4. Canada: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
9.4. Companion Animal Vaccines Market - Europe
- 9.4.1. Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.2. Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.3. Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.4. Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.5. Companion Animal Vaccines Market - UK
  - 9.4.5.1. UK: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.4.5.2. UK: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.4.5.3. UK: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.4.5.4. UK: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.6. Companion Animal Vaccines Market - France
  - 9.4.6.1. France: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.4.6.2. France: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.4.6.3. France: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.4.6.4. France: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.7. Companion Animal Vaccines Market - Germany
  - 9.4.7.1. Germany: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.4.7.2. Germany: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.4.7.3. Germany: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.4.7.4. Germany: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.8. Companion Animal Vaccines Market - Italy
  - 9.4.8.1. Italy: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.4.8.2. Italy: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.4.8.3. Italy: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.4.8.4. Italy: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.9. Companion Animal Vaccines Market - Spain
  - 9.4.9.1. Spain: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.4.9.2. Spain: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.4.9.3. Spain: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.4.9.4. Spain: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.10. Companion Animal Vaccines Market - Netherlands
  - 9.4.10.1. Netherlands: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.4.10.2. Netherlands: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.4.10.3. Netherlands: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.4.10.4. Netherlands: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.11. Companion Animal Vaccines Market - Russia
  - 9.4.11.1. Russia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.4.11.2. Russia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.4.11.3. Russia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.4.11.4. Russia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.12. Companion Animal Vaccines Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.4.12.2. Rest of Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.4.12.3. Rest of Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.4.12.4. Rest of Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
9.5. Companion Animal Vaccines Market - Asia Pacific
- 9.5.1. Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.5. Companion Animal Vaccines Market - China
  - 9.5.5.1. China: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.5.5.2. China: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.5.5.3. China: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.5.5.4. China: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.6. Companion Animal Vaccines Market - India
  - 9.5.6.1. India: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.5.6.2. India: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.5.6.3. India: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.5.6.4. India: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.7. Companion Animal Vaccines Market - Malaysia
  - 9.5.7.1. Malaysia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.5.7.2. Malaysia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.5.7.3. Malaysia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.5.7.4. Malaysia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.8. Companion Animal Vaccines Market - Japan
  - 9.5.8.1. Japan: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.5.8.2. Japan: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.5.8.3. Japan: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.5.8.4. Japan: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.9. Companion Animal Vaccines Market - Indonesia
  - 9.5.9.1. Indonesia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.5.9.2. Indonesia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.5.9.3. Indonesia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.5.9.4. Indonesia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.10. Companion Animal Vaccines Market - South Korea
  - 9.5.10.1. South Korea: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.5.10.2. South Korea: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.5.10.3. South Korea: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.5.10.4. South Korea: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.11. Companion Animal Vaccines Market - Australia
  - 9.5.11.1. Australia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.5.11.2. Australia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.5.11.3. Australia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.5.11.4. Australia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.12. Companion Animal Vaccines Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
9.6. Companion Animal Vaccines Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.5. Companion Animal Vaccines Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.6.5.2. Saudi Arabia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.6.5.3. Saudi Arabia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.6.5.4. Saudi Arabia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.6. Companion Animal Vaccines Market - UAE
  - 9.6.6.1. UAE: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.6.6.2. UAE: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.6.6.3. UAE: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.6.6.4. UAE: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.7. Companion Animal Vaccines Market - Israel
  - 9.6.7.1. Israel: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.6.7.2. Israel: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.6.7.3. Israel: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.6.7.4. Israel: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.8. Companion Animal Vaccines Market - South Africa
  - 9.6.8.1. South Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.6.8.2. South Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.6.8.3. South Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.6.8.4. South Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.9. Companion Animal Vaccines Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
9.7. Companion Animal Vaccines Market - Latin America
- 9.7.1. Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.2. Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.3. Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.4. Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.5. Companion Animal Vaccines Market - Mexico
  - 9.7.5.1. Mexico: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.7.5.2. Mexico: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.7.5.3. Mexico: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.7.5.4. Mexico: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.6. Companion Animal Vaccines Market - Brazil
  - 9.7.6.1. Brazil: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.7.6.2. Brazil: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.7.6.3. Brazil: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.7.6.4. Brazil: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.7. Companion Animal Vaccines Market - Argentina
  - 9.7.7.1. Argentina: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.7.7.2. Argentina: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.7.7.3. Argentina: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.7.7.4. Argentina: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.8. Companion Animal Vaccines Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  - 9.7.8.2. Rest of Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  - 9.7.8.3. Rest of Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  - 9.7.8.4. Rest of Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Bimeda Biologicals
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Boehringer Ingelheim Animal Health
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Calier
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Ceva
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Elanco
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Merck & Co., Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Neogen Corporation
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Phibro Animal Health Corporation
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Virbac
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Zoetis
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development